These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18550854

  • 1. Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis.
    Kassouf MT, Chagraoui H, Vyas P, Porcher C.
    Blood; 2008 Aug 15; 112(4):1056-67. PubMed ID: 18550854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. SCL/TAL1: a multifaceted regulator from blood development to disease.
    Porcher C, Chagraoui H, Kristiansen MS.
    Blood; 2017 Apr 13; 129(15):2051-2060. PubMed ID: 28179281
    [Abstract] [Full Text] [Related]

  • 4. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
    Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH.
    Cell; 1996 Jul 12; 86(1):47-57. PubMed ID: 8689686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
    Göttgens B, Broccardo C, Sanchez MJ, Deveaux S, Murphy G, Göthert JR, Kotsopoulou E, Kinston S, Delaney L, Piltz S, Barton LM, Knezevic K, Erber WN, Begley CG, Frampton J, Green AR.
    Mol Cell Biol; 2004 Mar 12; 24(5):1870-83. PubMed ID: 14966269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding.
    Porcher C, Liao EC, Fujiwara Y, Zon LI, Orkin SH.
    Development; 1999 Oct 12; 126(20):4603-15. PubMed ID: 10498694
    [Abstract] [Full Text] [Related]

  • 10. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T, Lambert JA, Martin R.
    Curr Top Dev Biol; 2016 Oct 12; 118():163-204. PubMed ID: 27137657
    [Abstract] [Full Text] [Related]

  • 11. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
    Chan WY, Follows GA, Lacaud G, Pimanda JE, Landry JR, Kinston S, Knezevic K, Piltz S, Donaldson IJ, Gambardella L, Sablitzky F, Green AR, Kouskoff V, Göttgens B.
    Blood; 2007 Mar 01; 109(5):1908-16. PubMed ID: 17053063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM, Schuh A, Flitter S, Fisher A, Mikkola H, Orkin SH, Vyas P, Porcher C.
    Mol Cell Biol; 2004 Sep 01; 24(17):7491-502. PubMed ID: 15314159
    [Abstract] [Full Text] [Related]

  • 17. The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification.
    Hochman E, Kinston S, Harmelin A, Göttgens B, Izraeli S.
    Exp Hematol; 2006 Dec 01; 34(12):1643-50. PubMed ID: 17157160
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
    Robb L, Lyons I, Li R, Hartley L, Köntgen F, Harvey RP, Metcalf D, Begley CG.
    Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):7075-9. PubMed ID: 7624372
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.